Clin2
NCT05839938Possibly a fitEnrolling by invitation

Vitamin D study for kids with allergic conjunctivitis

Allergic Conjunctivitis

Treatments studied

Part of Eyes & vision, Immune system & allergy clinical trials.

This trial studies whether vitamin D affects the surface of the eye, the eye’s normal germs, eye inflammation, and vision in children with allergic conjunctivitis. If vitamin D helps, it could improve symptoms and eye comfort.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
6 years to 18 years
Study type
Interventional

Who can take part

  • Be a child age 6 to 18 with allergic conjunctivitis diagnosed by an eye or allergy specialist
  • Have not had any eye surgery in the past
  • Do not have an active eye infection right now
  • Do not have any eye inflammation/eye disease other than allergic conjunctivitis
  • Haven’t used oral or other systemic (whole-body) steroids within the last 28 days

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686472Recruiting· Phase 2
Testing TL-925 eye drops for allergic conjunctivitis

This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.

Memphis, Tennessee
NCT07675811Recruiting· Phase 3
Study of a new treatment for cat allergy related eye symptoms

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Andover, Massachusetts
NCT07220408Recruiting· Phase 2
TL-925 eye drops for seasonal eye allergies

This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.

Smyrna, Tennessee
NCT06793514Not yet recruiting· Phase 1
Probiotics for children with eye allergy

This trial tests whether taking oral probiotics can improve eye symptoms and gut health in children with vernal keratoconjunctivitis, a severe type of eye allergy. It is for children aged 4 to 18 who haven't recently used certain medications or supplements.

NCT07171307Not yet recruiting
Immune cells in allergic conjunctivitis and allergy shots

This study looks at how immune cells work in people with allergic conjunctivitis and whether allergy shots (desensitization therapy) can help. It aims to understand the balance of certain immune cells in your eyes and blood.

Mexico City, Mexico City
NCT05043116Recruiting· Phase 2
Vitamin D for preventing asthma-like flare-ups in young children

This study tests whether a high-dose vitamin D supplement can help preschool children have fewer acute asthma-like symptoms (coughing, wheezing, or trouble breathing) that require hospital care. It may help by supporting the immune and airway system, but you can only join if the child meets several safety and treatment criteria.

Gentofte Municipality, Gentofte

Hear when a new Allergic Conjunctivitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.